RESUMEN
The Tympanic Membrane (TM) transforms acoustic energy to ossicular vibration. The shape and the displacement of the TM play an important role in this process. We developed a High-speed Digital Holography (HDH) system to measure the shape and transient displacements of the TM induced by acoustic clicks. The displacements were further normalized by the measured shape to derive surface normal displacements at over 100,000 points on the TM surface. Frequency and impulse response analyses were performed at each TM point, which enable us to describe 2D surface maps of four new TM mechanical parameters. From frequency domain analyses, we describe the (i) dominant frequencies of the displacement per sound pressure based on Frequency Response Function (FRF) at each surface point. From time domain analyses, we describe the (ii) rising time, (iii) exponential decay time, and the (iv) root-mean-square (rms) displacement of the TM based on Impulse Response Function (IRF) at each surface point. The resultant 2D maps show that a majority of the TM surface has a dominant frequency of around 1.5 kHz. The rising times suggest that much of the TM surface is set into motion within 50 µs of an impulsive stimulus. The maps of the exponential decay time of the IRF illustrate spatial variations in damping, the least known TM mechanical property. The damping ratios at locations with varied dominant frequencies are quantified and compared.
Asunto(s)
Holografía , Membrana Timpánica , Estimulación Acústica , Oído Medio , Sonido , Membrana Timpánica/diagnóstico por imagen , VibraciónRESUMEN
In this paper, we propose a multi-pulsed double exposure (MPDE) acquisition method to quantify in full-field-of-view the transient (i.e., >10 kHz) acoustically induced nanometer scale displacements of the human tympanic membrane (TM or eardrum). The method takes advantage of the geometrical linearity and repeatability of the TM displacements to enable high-speed measurements with a conventional camera (i.e., <20 fps). The MPDE is implemented on a previously developed digital holographic system (DHS) to enhance its measurement capabilities, at a minimum cost, while avoiding constraints imposed by the spatial resolutions and dimensions of high-speed (i.e., >50 kfps) cameras. To our knowledge, there is currently no existing system to provide such capabilities for the study of the human TM. The combination of high temporal (i.e., >50 kHz) and spatial (i.e., >500k data points) resolutions enables measurements of the temporal and frequency response of all points across the surface of the TM simultaneously. The repeatability and accuracy of the MPDE method are verified against a Laser Doppler Vibrometer (LDV) on both artificial membranes and ex-vivo human TMs that are acoustically excited with a sharp (i.e., <100 µs duration) click. The measuring capabilities of the DHS, enhanced by the MPDE acquisition method, allow for quantification of spatially dependent motion parameters of the TM, such as modal frequencies, time constants, as well as inferring local material properties.
RESUMEN
Micrometre- and submicrometre-size functionalized beads are frequently used to capture targets of interest from a biological sample for biological characterizations and disease diagnosis. The main challenge of the microbead-based assay is in the immobilization of probe molecules onto the microbead surfaces. In this paper, we report a versatile droplet microfluidics method to fabricate alginate microspheres while simultaneously immobilizing anti-Mycobacterium tuberculosis complex IgY and anti-Escherichia coli IgG antibodies primarily on the porous alginate carriers for specific binding and binding affinity tests. The binding affinity of antibodies is directly measured by fluorescence intensity of stained target bacteria on the microspheres. We demonstrate that the functionalized alginate microspheres yield specificity comparable with an enzyme-linked immunosorbent assay. The high surface area-to-volume ratio of the functionalized porous alginate microspheres improves the detection limit. By using the droplet microfluidics, we can easily modify the size and shape of alginate microspheres, and increase the concentration of functionalized alginate microspheres to further enhance binding kinetics and enable multiplexing.
Asunto(s)
Alginatos/química , Proteínas Inmovilizadas/química , Inmunoglobulina G/química , Inmunoglobulinas/química , Técnicas Analíticas Microfluídicas , Microesferas , Anticuerpos Antibacterianos/química , Anticuerpos Antibacterianos/inmunología , Escherichia coli/inmunología , Ácido Glucurónico/química , Ácidos Hexurónicos/química , Proteínas Inmovilizadas/inmunología , Inmunoglobulina G/inmunología , Inmunoglobulinas/inmunología , Mycobacterium tuberculosis/inmunologíaRESUMEN
Paraoxonase 2 (PON2), a member of a gene family that also includes PON1 and PON3, is expressed in most tissues, including the brain. In mouse brain, PON2 levels are highest in dopaminergic areas (e.g., striatum) and are higher in astrocytes than in neurons. PON2 is primarily located in mitochondria and exerts a potent antioxidant effect, protecting mouse CNS cells against oxidative stress. The aim of this study was to characterize PON2 expression and functions in the brains of male and female mice. Levels of PON2 (protein, mRNA, and lactonase activity) were higher in brain regions and cells of female mice. Astrocytes and neurons from male mice were significantly more sensitive (by 3- to 4-fold) to oxidative stress-induced toxicity than the same cells from female mice. Glutathione levels did not differ between genders. Importantly, no significant gender differences in susceptibility to the same oxidants were seen in cells from PON2(-/-) mice. Treatment with estradiol induced a time- and concentration-dependent increase in the levels of PON2 protein and mRNA in male (4.5-fold) and female (1.8-fold) astrocytes, which was dependent on activation of estrogen receptor-α. In ovariectomized mice, PON2 protein and mRNA were decreased to male levels in brain regions and in liver. Estradiol protected astrocytes from wild-type mice against oxidative stress-induced neurotoxicity, but did not protect cells from PON2(-/-) mice. These results suggest that PON2 is a novel major intracellular factor that protects CNS cells against oxidative stress and confers gender-dependent susceptibility to such stress. The lower expression of PON2 in males may have broad ramifications for susceptibility to diseases involving oxidative stress, including neurodegenerative diseases.
Asunto(s)
Arildialquilfosfatasa/metabolismo , Encéfalo/metabolismo , Sistema Nervioso Central/patología , Estrés Oxidativo , Animales , Astrocitos/metabolismo , Astrocitos/patología , Encéfalo/patología , Sistema Nervioso Central/metabolismo , Femenino , Predisposición Genética a la Enfermedad , Masculino , Ratones , Neuronas/metabolismo , Neuronas/patología , Caracteres SexualesRESUMEN
Twenty-two confirmed cases of Salmonella Infantis were identified in 70 residents of high-level care areas of a residential aged care facility in Sydney in April 2010 during an outbreak of gastroenteritis. A retrospective cohort study was conducted to identify a possible cause. Consuming a soft diet, puréed diet, or thickened fluid were each independently associated with illness. A logistic regression showed consumption of thickened fluid to be the only significant exposure associated with illness (adjusted odds ratio 11·8, 95% confidence interval 1·9-75·9). It was postulated that the thickened fluid had been contaminated by chicken mince, a sample of which also cultured S. Infantis. This finding reinforces the need to educate food-handlers on the risk of potential cross-contamination; it also highlights the need to consider all dietary components, such as thickened fluids, as potential vehicles for transmission in an outbreak.
Asunto(s)
Bebidas/microbiología , Brotes de Enfermedades , Microbiología de Alimentos , Gastroenteritis/epidemiología , Infecciones por Salmonella/epidemiología , Salmonella enterica , Anciano , Anciano de 80 o más Años , Intervalos de Confianza , Diarrea/microbiología , Dieta , Femenino , Gastroenteritis/microbiología , Hogares para Ancianos , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Nueva Gales del Sur/epidemiología , Oportunidad Relativa , Estudios Retrospectivos , Infecciones por Salmonella/microbiología , Viscosidad , Vómitos/microbiologíaRESUMEN
BACKGROUND: The Quality and Outcomes Framework, a financial incentive scheme for general practitioners in the UK, seems to have improved the quality of primary care and reduced inequalities in primary care delivery. It remains unclear, however, whether higher-quality primary care improves health outcomes or reduces health inequalities. METHODS: We conducted a cross-sectional study examining the association between quality of cardiovascular care and coronary heart disease (CHD) outcomes in 1531 general practices in London. We calculated CHD quality achievement scores (ranging from 0 to 100) for each practice using the 2006-2007 data from the Quality and Outcomes Framework. We used weighted linear regression models to assess the practice-level association between the CHD quality score and CHD admissions and deaths. FINDINGS: Overall, practices with higher CHD quality achievement scores had better CHD outcomes. Each one point increase in the CHD quality achievement score was associated with 4.28 (95% CI 1.19 to 7.38; p=0.007) fewer admissions per 100,000 for practices serving highly deprived populations and 2.11 (95% CI 0.68 to 3.55; p=0.004) fewer admissions per 100 000 for practices serving populations of average deprivation. There was no association between the CHD quality achievement score and the CHD admissions for practices serving affluent populations (p=0.906). We observed a similar deprivation-dependent gradient between quality achievement and CHD deaths. INTERPRETATION: High-quality primary care is associated with improved health outcomes. This association is strongest in deprived areas, suggesting that high-quality primary care may play an important role in reducing health inequalities.
Asunto(s)
Enfermedad Coronaria/terapia , Medicina Familiar y Comunitaria/normas , Disparidades en Atención de Salud , Pobreza , Garantía de la Calidad de Atención de Salud , Indicadores de Calidad de la Atención de Salud , Adulto , Anciano , Competencia Clínica , Enfermedad Coronaria/diagnóstico , Estudios Transversales , Femenino , Tamaño de las Instituciones de Salud/estadística & datos numéricos , Disparidades en Atención de Salud/normas , Disparidades en Atención de Salud/estadística & datos numéricos , Humanos , Londres/epidemiología , Masculino , Persona de Mediana Edad , Planes de Incentivos para los Médicos , Pautas de la Práctica en Medicina/normas , Pautas de la Práctica en Medicina/estadística & datos numéricos , Atención Primaria de Salud/normas , Garantía de la Calidad de Atención de Salud/normas , Análisis de Regresión , Resultado del TratamientoRESUMEN
Human paraoxonase 1 (PON1) is a high-density lipoprotein (HDL)-associated serum enzyme that exhibits a broad substrate specificity. In addition to protecting against exposure to some organophosphorus (OP) pesticides by hydrolyzing their toxic oxon metabolites, PON1 is important in protecting against vascular disease by metabolizing oxidized lipids. Recently, PON1 has also been shown to play a role in inactivating the quorum sensing factor N-(3-oxododecanoyl)-l-homoserine lactone (3OC12-HSL) of Pseudomonas aeruginosa. Native, untagged engineered recombinant human PON1 (rHuPON1) expressed in Escherichia coli and purified by conventional column chromatographic purification is stable, active, and capable of protecting PON1 knockout mice (PON1(-/-)) from exposure to high levels of the OP compound diazoxon. The bacterially derived rHuPON1 can be produced in large quantities and lacks the glycosylation of eukaryotic systems that can produce immunogenic complications when inappropriately glycosylated recombinant proteins are used as therapeutics. Previous studies have shown that the determination of PON1 status, which reveals both PON1(192) functional genotype and serum enzyme activity level, is required for a meaningful evaluation of PON1's role in risk of disease or exposure. We have developed a new two-substrate assay/analysis protocol that provides PON1 status without use of toxic OP substrates, allowing for use of this protocol in non-specialized laboratories. Factors were also determined for inter-converting rates of hydrolysis of different substrates. PON1 status also plays an important role in revealing changes in HDL-associated PON1 activities in male patients with Parkinson disease (PD). Immunolocalization studies of PONs 1, 2 and 3 in nearly all mouse tissues suggest that the functions of PONs 1 and 3 extend beyond the plasma and the HDL particle.
Asunto(s)
Arildialquilfosfatasa/metabolismo , Enfermedad , Exposición a Riesgos Ambientales/efectos adversos , Intoxicación por Organofosfatos , Animales , Arildialquilfosfatasa/genética , Arildialquilfosfatasa/uso terapéutico , Biomarcadores/metabolismo , Humanos , RiesgoRESUMEN
Computer-aided, personal computer (PC) based, optoelectronic holography (OEH) was used to obtain preliminary measurements of the sound-induced displacement of the tympanic membrane (TM) of cadaver cats and chinchillas. Real-time time-averaged holograms, processed at video rates, were used to characterise the frequency dependence of TM displacements as tone frequency was swept from 400 Hz to 20 kHz. Stroboscopic holography was used at selected frequencies to measure, in full-field-of-view, displacements of the TM surface with nanometer resolution. These measurements enable the determination and the characterisation of inward and outward displacements of the TM. The time-averaged holographic data suggest standing wave patterns on the cat's TM surface, which move from simple uni-modal or bi-modal patterns at low frequencies, through complicated multimodal patterns above 3 kHz, to highly ordered arrangements of displacement waves with tone frequencies above 15 kHz. The frequency boundaries of the different wave patterns are lower in chinchilla (simple patterns below 600 Hz, ordered patterns above 4 kHz) than cat. The stroboscopic holography measurements indicate wave-like motion patterns on the TM surface, where the number of wavelengths captured along sections of the TM increased with stimulus frequency with as many as 11 wavelengths visible on the chinchilla TM at 16 kHz. Counts of the visible number of wavelengths on TM sections with different sound stimulus frequency provided estimates of wave velocity along the TM surface that ranged from 5 m s(-1) at frequencies below 8 kHz and increased to 25 m s(-1) by 20 kHz.
RESUMEN
OBJECTIVE: Four recent studies report a genetic association of the paraoxonase locus with sporadic amyotrophic lateral sclerosis (ALS). We tested the hypothesis that this association correlates with functional changes in paraoxonase 1 (PON1, MIM 168820). METHODS: Sera from 140 ALS participants; 153 age-, race-, and sex-matched controls; and 30 matched CSF samples were tested for paraoxonase, diazoxonase, and arylesterase activities. Participants with ALS were genotyped using tagging single nucleotide polymorphisms across the PON locus. Survival data and enzyme activity were correlated with genotype. RESULTS: There was a trend toward increased paraoxonase activity in ALS compared with controls (mean control paraoxonase 701.9 +/- 469.7 U/L, mean ALS 792.5 +/- 574.1 U/L; p = 0.066 after correction) which correlated with increased frequency of the homozygous arginine (RR) variant of PON1(Q192R) (p = 0.004). There was no significant difference in PON1 protein levels, or arylesterase or diazoxonase activities. Organophosphate hydrolysis rates had no effect on ALS survival. CONCLUSIONS: Contrary to expectations, PON1 protein, paraoxonase, diazoxonase, and arylesterase activities were not reduced in amyotrophic lateral sclerosis (ALS). The increase in PON1(R192) frequency in ALS in our study supports previous genetic susceptibility studies. Our findings suggest that the influence of PON1 polymorphisms on ALS susceptibility is not due to reduced organophosphate hydrolysis.
Asunto(s)
Esclerosis Amiotrófica Lateral/sangre , Esclerosis Amiotrófica Lateral/enzimología , Arildialquilfosfatasa/sangre , Predisposición Genética a la Enfermedad/genética , Organofosfatos/metabolismo , Polimorfismo Genético/genética , Esclerosis Amiotrófica Lateral/genética , Arildialquilfosfatasa/análisis , Arildialquilfosfatasa/genética , Biomarcadores/análisis , Biomarcadores/sangre , Hidrolasas de Éster Carboxílico/análisis , Hidrolasas de Éster Carboxílico/sangre , Hidrolasas de Éster Carboxílico/genética , Estudios de Cohortes , Análisis Mutacional de ADN , Regulación hacia Abajo/genética , Activación Enzimática/genética , Femenino , Frecuencia de los Genes , Pruebas Genéticas , Genotipo , Humanos , Hidrólisis , Isoenzimas/sangre , Isoenzimas/genética , Masculino , Valor Predictivo de las Pruebas , Regulación hacia Arriba/genéticaAsunto(s)
Esterasas/genética , Sistemas de Lectura Abierta/genética , Enfermedad de Parkinson/genética , Polimorfismo Genético/genética , Regiones Promotoras Genéticas/genética , Adulto , Anciano , Anciano de 80 o más Años , Arildialquilfosfatasa , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
The purpose of this investigation was twofold. The first objective was to demonstrate that, in most of ten mammalian species commonly used in biomedical research, not all constitutive heterochromatin (C-bands) represents telomeric DNA. For example, the C-bands in human chromosomes, the long arm of the X and the entire Y chromosome of Chinese hamster, and most of the short arms of Peromyscus and Syrian hamster chromosomes are not telomeric DNA. In addition to the usual terminal telomeric DNA in the chromosomes of these mammalian species, the pericentromeric regions of seven or eight Syrian hamster chromosomes and all Chinese hamster chromosomes except pair one have pericentromeric regions that hybridize with telomeric DNA, some in C-bands and some not. The second objective was to describe a simple fluorescence in situ hybridization (FISH) reverse-printing procedure to produce black-and-white microphotographs of metaphase and interphase cells showing locations of telomeric DNA with no loss of resolution. Thus, at least three different types of heterochromatin (telomeric heterochromatin, nontelomeric heterochromatin and a combination of both) are present in these mammalian species, and this simple black-and-white reverse printing of telomeric FISH preparations can depict them economically without sacrificing clarity.
Asunto(s)
ADN/química , Heterocromatina/química , Hibridación Fluorescente in Situ/métodos , Telómero/química , Animales , Células Cultivadas , Centrómero/química , Bandeo Cromosómico , ADN/genética , Diploidia , Femenino , Heterocromatina/genética , Humanos , Procesamiento de Imagen Asistido por Computador , Cariotipificación , Masculino , Piel/citología , Especificidad de la Especie , Cromosoma Y/químicaRESUMEN
Human HDL-associated paraoxonase (PON1) hydrolyzes a number of toxic organophosphorous compounds and reduces oxidation of LDLs and HDLs. These properties of PON1 account for its ability to protect against pesticide poisonings and atherosclerosis. PON1 also hydrolyzes a number of lactone and cyclic-carbonate drugs. Among individuals in a population, PON1 levels vary widely. We previously identified three polymorphisms in the PON1 regulatory region that affect expression levels in cultured human hepatocytes. In this study, we determined the genotypes of three regulatory-region polymorphisms for 376 white individuals and examined their effect on plasma-PON1 levels, determined by rates of phenylacetate hydrolysis. The -108 polymorphism had a significant effect on PON1-activity level, whereas the -162 polymorphism had a lesser effect. The -909 polymorphism, which is in linkage disequilibrium with the other sites, appears to have little or no independent effect on PON1-activity level in vivo. Other studies have found that the L55M polymorphism in the PON1-coding region is associated with differences in both PON1-mRNA and PON1-activity levels. The results presented here indicate that the L55M effect of lowered activity is not due to the amino acid change but is, rather, largely due to linkage disequilibrium with the -108 regulatory-region polymorphism. The codon 55 polymorphism marginally appeared to account for 15.3% of the variance in PON1 activity, but this dropped to 5% after adjustments for the effects of the -108 and Q192R polymorphisms were made. The -108C/T polymorphism accounted for 22.8% of the observed variability in PON1-expression levels, which was much greater than that attributable to the other PON1 polymorphisms. We also identified four sequence differences in the 3' UTR of the PON1 mRNA.
Asunto(s)
Hidrolasas de Éster Carboxílico/genética , Esterasas/genética , Regulación Enzimológica de la Expresión Génica , Polimorfismo Genético/genética , Regiones Promotoras Genéticas/genética , Regiones no Traducidas 3'/genética , Arildialquilfosfatasa , Hidrolasas de Éster Carboxílico/sangre , Hidrolasas de Éster Carboxílico/metabolismo , Células Cultivadas , Esterasas/sangre , Esterasas/metabolismo , Femenino , Frecuencia de los Genes/genética , Genotipo , Hepatocitos , Humanos , Hidrólisis , Desequilibrio de Ligamiento/genética , Masculino , Datos de Secuencia Molecular , Mutación/genética , Fenilacetatos/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Población Blanca/genéticaRESUMEN
Paraoxonase (PON1) is a protein component of high-density lipoprotein (HDL) particles that protects against oxidative damage to both low-density lipoprotein and HDL and detoxifies organophosphorus pesticides and nerve agents. A wide range of expression levels of PON1 among individuals has been observed. We examined the promoter region of PON1 for genetic factors that might affect PON1 activity levels. We conducted a deletion analysis of the PON1 promoter region in transient transfection assays and found that cell-type specific promoter elements for liver and kidney are present in the first 200bp upstream of the coding sequence. Sequence analysis of DNA from a BAC clone and a YAC clone identified five polymorphisms in the first 1000 bases upstream of the coding region at positions -108, -126, -162, -832 and -909. Additionally, the promoter sequences of two individuals expressing high levels of PON1 and two individuals expressing low levels of PON1 were analysed. The two polymorphisms at -126 and -832 had no apparent effect on expression level in the reporter gene assay. The polymorphisms at position -909, -162 (a potential NF-I transcription factor binding site) and -108 (a potential SP1 binding site) each have approximately a two-fold effect on expression level. The expression level effects of the three polymorphisms appear not to be strictly additive and may depend on context effects.
Asunto(s)
Esterasas/genética , Polimorfismo Genético/genética , Regiones Promotoras Genéticas/genética , Arildialquilfosfatasa , Línea Celular , Esterasas/biosíntesis , Regulación de la Expresión Génica , Haplotipos , Humanos , Mutagénesis Sitio-Dirigida , Transfección , Células Tumorales CultivadasRESUMEN
The paraoxonase (PON1) PON1-Q192R and PON1-L55M polymorphisms have been inconsistently associated with vascular disease. Plasma PON1 activity phenotypes vary markedly within genotypes and were, therefore, expected to add to the informativeness of genotype for predicting vascular disease. The case-control sample included 212 age- and race-matched men (mean age 66.4 years). The 106 carotid artery disease (CAAD) cases had >80% carotid stenosis, and the 106 controls had <15%. Two PON1 substrate hydrolysis rates (paraoxon [POase] and diazoxon [DZOase]) were significantly lower in cases than in controls and were significant predictors of CAAD by use of logistic regression (POase, P=0.005; DZOase, P=0.019). DZOase predicted vascular disease independently of lipoprotein profile, high density lipoprotein subfractions, apolipoprotein A-I, and smoking. PON1-192 and PON1-55 genotypes or haplotypes did not predict case-control status unless the activity phenotype was also included as a predictor by use of logistic regression. When phenotype was included as a predictor, PON1-192 and PON1-55 genotypes or combined haplotypes were significant predictors (P<0.05). In conclusion, examining PON1-192 and/or PON1-55 genotypes alone may mistakenly lead to the conclusion that there is no role of PON1 in CAAD. These results support the benefit of a "level crossing" approach that includes intervening phenotypes in the study of complexly inherited disease.
Asunto(s)
Estenosis Carotídea/enzimología , Estenosis Carotídea/genética , Esterasas/genética , Anciano , Anciano de 80 o más Años , Sustitución de Aminoácidos/genética , Arginina/genética , Arildialquilfosfatasa , Estudios de Casos y Controles , Genotipo , Glutamina/genética , Haplotipos , Humanos , Isoenzimas/genética , Leucina/genética , Masculino , Metionina/genética , Persona de Mediana Edad , Compuestos Organofosforados/metabolismo , Paraoxon/metabolismo , Fenotipo , Valor Predictivo de las Pruebas , Factores de RiesgoRESUMEN
It has been assumed since its discovery that serum paraoxonase (PON1) plays a major role in the detoxication of specific organophosphorus compounds. It was also assumed that individuals with low PON1 activity would be more susceptible to paraoxon/parathion poisoning than individuals with higher PON1 activity. Evidence supporting this hypothesis was provided by injection of rabbit PON1 into rodents. Injected PON1 protected against paraoxon toxicity in rats and chlorpyrifos oxon toxicity in mice. The recent availability of PON1 knockout mice has provided an in vivo system with which one can more closely examine the role of PON1 in detoxication. PON1 knockout mice demonstrated dramatically increased sensitivity to chlorpyrifos oxon and diazoxon and moderately increased sensitivity to the respective parent compounds. The PON1 knockout mutation also resulted in the elimination of liver PON1 activity, accounting for the dramatic increase in sensitivity to chlorpyrifos oxon and diazoxon. Totally unexpected was our finding that the PON1 knockout mice were not more sensitive to paraoxon. This was particularly surprising in light of the earlier enzyme injection experiments. Differences in the relative catalytic efficiencies of rabbit vs. mouse PON1 for the specific oxon forms explain these observations. Mouse PON1 has good catalytic efficiency for the hydrolysis of diazoxon and chlorpyrifos oxon, but a poor efficiency for paraoxon hydrolysis relative to rabbit PON1. The human PON1Q192 isoform has a catalytic efficiency similar to that of mice, whereas the human PON1R192 isoform has a much better catalytic efficiency, predicting that individuals expressing high levels of the PONIR192 isoform may have increased resistance to paraoxon toxicity.
Asunto(s)
Esterasas/genética , Compuestos Organofosforados/toxicidad , Animales , Arildialquilfosfatasa , Cloropirifos/análogos & derivados , Cloropirifos/metabolismo , Esterasas/metabolismo , Frecuencia de los Genes , Genotipo , Cobayas , Humanos , Insecticidas/metabolismo , Hígado/enzimología , Ratones , Ratones Noqueados , Compuestos Organofosforados/metabolismo , Paraoxon/metabolismo , Conejos , Reacción en Cadena de la Polimerasa de Transcriptasa InversaRESUMEN
Paraoxonase (PON1) is tightly associated with high-density lipoprotein particles and is believed to contribute to the prevention of atherosclerosis by metabolizing oxidized lipids. PON1 also hydrolyses the bioactive oxon forms of organophosphorus pesticides such as parathion, diazinon and chlorpyrifos. Two common polymorphisms have been identified in the coding sequence of human PON1: L55M and R192Q. Several previous studies have found that the presence of the PON1R192 allele raises the risk of cardiovascular disease while others found no correlation. The studies, however, have focused on the genotype of PON1 and not the expression level of the protein. We found that the PON1 expression level in plasma, as determined by the rates of paraoxon and diazoxon hydrolysis, varies widely among individuals and within a genotype. Previous studies found that individuals having Met at PON155 have lower levels of both PON1 mRNA and activity. In this study, we determined the plasma activity levels of PON1 and examined the relationships between PON155 genotype and PON1 level. As with PON1192, we found considerable overlap in activity among the PON155 genotypes. Of the 317 individuals whose PON1 status was determined in this study, 48.9% were PON1Q192 homozygotes. Analysis of the PON1QQ192 population showed that while the average PON1 activity (diazoxon hydrolysis) was 12266 U/L for PON1LL55 and 7777 U/L for PON1MM55, a given PONMM55 individual could have more than twice the activity of a PON1LL55 individual. PON1 status, which includes PON1 level as well as PON1192 genotype, may be a better predictor for cardiovascular disease or organophosphate susceptibility than PON1 genotype alone.
Asunto(s)
Esterasas/genética , Esterasas/metabolismo , Leucina/genética , Metionina/genética , Anciano , Anciano de 80 o más Años , Sustitución de Aminoácidos/genética , Arildialquilfosfatasa , Activación Enzimática/genética , Esterasas/sangre , Femenino , Tamización de Portadores Genéticos , Genotipo , Humanos , Masculino , Persona de Mediana Edad , Fenotipo , Polimorfismo Genético/genéticaRESUMEN
Susceptibility to organophosphorus (OP) insecticides and nerve agents is strongly influenced by genetic and developmental factors. A number of organophosphorothioate insecticides are detoxified in part via a two-step pathway involving bioactivation of the parent compound by the cytochrome P450 systems, then hydrolysis of the resulting oxygenated metabolite (oxon) by serum and liver paraoxonases (PON1). Serum PON1 has been shown to be polymorphic in human populations. The Arg192 isoform (PON1R192) of this HDL-associated protein hydrolyzes paraoxon (POX) at a high rate, while the Gln192 isoform (PON1Q192) hydrolyzes paraoxon at a low rate. The effect of the polymorphism is reversed for the hydrolysis of diazoxon (DZO), soman and particularly sarin. Phenylacetate is hydrolyzed at approximately the same rate by both PON1 isoforms and chlorpyrifos oxon (CPO) slightly faster by the PON1R192 isoform. In addition to the effect of the amino acid substitution on rates of toxicant hydrolysis, two other factors influence these rates. The expression of PON1 is developmentally regulated. Newborns have very low levels of PON1. Adult levels in rats and mice are reached at 3 weeks of age and in humans, sometime after 6 months of age. In addition, among individuals of a given genotype, there is at least a 13-fold difference in expression of PON1 that is stable over time. Dose/response experiments with normal mice injected with purified PON1 and with PON1 knockout mice have clearly demonstrated that the observed differences of in vitro rates of hydrolysis are significant in determining differential sensitivities to specific insecticides processed through the P450/PON1 pathway. Injection of purified rabbit PON1 protects mice from cholinesterase inhibition by chlorpyrifos (CPS) and CPO. Knockout mice are much more sensitive to CPO and DZO than are their PON1+/+ littermates or wild-type mice. A number of recent reports have also indicated that the PON1R192 isoform may be a risk factor for cardiovascular disease. Studies with PON1 knockout mice are also consistent with a role of PON1 in preventing vascular disease.
Asunto(s)
Esterasas/genética , Esterasas/metabolismo , Insecticidas/toxicidad , Síndromes de Neurotoxicidad/genética , Compuestos Organofosforados , Animales , Arildialquilfosfatasa , Humanos , Síndromes de Neurotoxicidad/enzimología , Especificidad de la EspecieAsunto(s)
Infecciones por Bacterias Grampositivas/enfermería , Infecciones por Bacterias Grampositivas/transmisión , Recien Nacido Prematuro , Transmisión Vertical de Enfermedad Infecciosa , Listeria/aislamiento & purificación , Adulto , Terapia Combinada , Femenino , Estudios de Seguimiento , Infecciones por Bacterias Grampositivas/terapia , Humanos , Recién Nacido , Unidades de Cuidado Intensivo Neonatal , Intercambio Materno-Fetal , Enfermería Neonatal/métodos , Embarazo , Respiración Artificial , Medición de Riesgo , Resultado del TratamientoRESUMEN
Human paraoxonase (PON1) is a polymorphic, high-density lipoprotein (HDL)-associated esterase that hydrolyzes the toxic metabolites of several organophosphorus (OP) insecticides and nerve agents. The activity polymorphism is determined by a Gln/Arg (Q/R) substitution at position 192. Injection of purified PON1 protects animals from OP poisoning. In the present study, we investigated the in-vivo function of PON1 for detoxifying organophosphorus insecticides in PON1-knockout mice that were challenged via dermal exposure with diazoxon, diazinon and paraoxon. PON1-knockout mice were extremely sensitive to diazoxon. Doses (2 and 4 mg/kg) that caused no cholinesterase (ChE) inhibition in wild-type mice were lethal to the knockout mice, which also showed slightly increased sensitivity to the parent compound diazinon. Surprisingly, these knockout mice did not show increased sensitivity to paraoxon. In-vitro assays indicated that the PON1R192 isoform hydrolyzed diazoxon less rapidly than did the PON1Q192 isoform. In-vivo analysis, where PON1-knockout mice received the same amount of either PON1(192) isoform via intraperitoneal (i.p.) injection 4 h prior to exposure, showed that both isoforms provided a similar degree of protection against diazoxon, while PON1R192 conferred better protection against chlorpyrifos-oxon than PON1Q192. Injection of purified rabbit PON1 or either human PON1(192) isoform did not protect PONI-knockout mice from paraoxon toxicity, nor did over-expression of the human PON1R192 transgene in wild-type mice. Kinetic analysis of the two human PON1(192) isoforms revealed that the catalytic efficiency (Vmax/Km) determines the in-vivo efficacy of PON1 for organophosphorus detoxication. The results indicate that PON1 plays a major role in the detoxication of diazoxon and chlorpyrifos oxon but not paraoxon.